TipRanks
Go Ultimate55% OFF

RedHill Biopharma (RDHL) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Rhb-204Lung Diseases, Bronchiectasis, Pulmonary Mycobacterium Avium Complex InfectionPhase IIITerminatedRHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex DiseaseOct 19, 2020―
OpaganibCovid-19, Lung Infectionphase2AndPhase3CompletedOpaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 PneumoniaJul 09, 2020―
Abc294640, Hydroxychloroquine Sulfate 200 MgCholangiocarcinoma, Cholangiocarcinoma Non-Resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma, PerihilarPhase IICompletedA Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced CholangiocarcinomaDec 01, 2017―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does RedHill Biopharma Ltd (RDHL) have in its pipeline
RedHill Biopharma RDHL is currently developing the following drugs: Rhb-204, Opaganib, Abc294640, Hydroxychloroquine Sulfate 200 Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.